OPTIMATA LTD

logo

  20 Zichron Yaa'Kov St. – Tel Aviv – 6299920

  VAT: IL512821802

   http://www.optimata.com


Complicit EU Projects


  Within the Horizon 2020 (2014-2020) framework, OPTIMATA LTD has received € 298,661.0 for its participation in a total of 3 project(s) with a total cost of € 13,208,986.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2014-12-01 642295 MEL-PLEX drug discovery  ·  melanoma  ·  simulation software  ·  mathematical model 2018-11-30 participant € 260,300.52 € 3,583,870 2 20 CORDIS ↪
2015-10-01 675448 TRAIN-ERS inflammatory diseases  ·  critical care medicine  ·  melanoma  ·  breast cancer  ·  amyotrophic lateral sclerosis 2019-09-30 participant € 0.0 € 3,628,756 1 18 CORDIS ↪
2018-01-01 754923 COLOSSUS gender equality  ·  colorectal cancer  ·  mutation  ·  personalized medicine  ·  employment 2023-06-30 participant € 38,361.6 € 5,996,359 1 14 CORDIS ↪

 OPTIMATA LTD did not participate in complicit projects under Horizon Europe (2021-2027).

  Within the FP7 (2007-2013) framework, OPTIMATA LTD has received € 608,438.0 for its participation in a total of 2 project(s) with a total cost of € 26,959,610.

Start (YYYYMMDD) Project ID Project Name Themes End (YYYYMMDD) Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2011-03-01 115156 DDMORE ontology  ·  software  ·  public health  ·  ecosystems  ·  mathematical model 2016-08-31 participant € 147,278.0 € 23,063,274 1 28 CORDIS ↪
2012-11-01 306021 APO-DECIDE drug discovery  ·  cell signaling  ·  colorectal cancer  ·  personalized medicine  ·  pharmacokinetics 2014-10-31 participant € 461,160.0 € 3,896,336 1 7 CORDIS ↪